World's Best Scientists 2026 revealed!

D-Index & Metrics

Immunology

D-Index
60
Citations
12716
World Ranking
3332
National Ranking
1546

Overview

Anthony T. Reder is affiliated with the University of Chicago in the United States. Their research is primarily situated within the field of Medicine, with significant contributions to subfields such as Pathology and Forensic Medicine, Neurology, Oncology, Immunology, and Molecular Biology.

Their work focuses extensively on Multiple Sclerosis Research Studies, Peripheral Neuropathies and Disorders, Cytokine Signaling Pathways and Interactions, Immunotherapy and Immune Responses, as well as Polyomavirus and related diseases. Other research areas include Rheumatoid Arthritis Research and Therapies and Systemic Lupus Erythematosus Research.

They have published in a variety of prominent venues, including:

  • Neurology
  • Multiple Sclerosis Journal
  • Multiple Sclerosis and Related Disorders
  • CNS Drugs
  • Frontiers in Neurology

Frequent collaborators in their research include Lilyana Amezcua, Nancy Monson, Timothy Vartanian, Mitzi Williams, and Gregory F. Wu.

Recent papers documenting their research contributions are:

  • COVID-19 in Patients with Multiple Sclerosis: Associations with Disease-Modifying Therapies, 2021, CNS Drugs
  • T cell responses to COVID-19 infection and vaccination in patients with multiple sclerosis receiving disease-modifying therapy, 2022, Multiple Sclerosis Journal

Other notable papers related to their research field, though not directly authored by them, provide context to the ongoing studies in multiple sclerosis:

  • Ocrelizumab treatment for relapsing-remitting multiple sclerosis after a suboptimal response to previous disease-modifying therapy: A nonrandomized controlled trial, 2021, Multiple Sclerosis Journal
  • Anti-CD20 therapy corrects a CD8 regulatory T cell deficit in multiple sclerosis, 2021, Multiple Sclerosis Journal
  • Understanding humoral immunity and multiple sclerosis severity in Black, and Latinx patients, 2023, Frontiers in Immunology

Best Publications

  • Safety and efficacy of fingolimod in patients with relapsing-remitting multiple sclerosis (FREEDOMS II): a double-blind, randomised, placebo-controlled, phase 3 trial.

    Peter A. Calabresi;Ernst Wilhelm Radue;Douglas Goodin;Douglas Jeffery

  • Cytokine levels in the cerebrospinal fluid and serum of patients with multiple sclerosis

    Davide Maimone;Susan Gregory;Barry G.W. Arnason;Anthony T. Reder

  • Mechanisms of action of disease-modifying agents and brain volume changes in multiple sclerosis

    R. Zivadinov;A. T. Reder;M. Filippi;A. Minagar

  • Cytokines in the Vitreous of Patients With Proliferative Diabetic Retinopathy

    Ahmed M. Abu El Asrar;Davide Maimone;Peter H. Morse;Susan Gregory

  • Recommendations for clinical use of data on neutralising antibodies to interferon-beta therapy in multiple sclerosis

    Chris H. Polman;Antonio Bertolotto;Florian Deisenhammer;Gavin Giovannoni

  • Increased CD80(+) B cells in active multiple sclerosis and reversal by interferon beta-1b therapy.

    K Genç;D L Dona;A T Reder

  • Neuroleukin: a lymphokine product of lectin-stimulated T cells.

    Mark E. Gurney;Brian R. Apatoff;Gregory T. Spear;Mark J. Baumel

  • Neutralizing antibodies to interferon beta: Assessment of their clinical and radiographic impact: An evidence report: Report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology

    D. S. Goodin;Elliot Frohman;B. Hurwitz;P. W. O'Connor

  • Estriol combined with glatiramer acetate for women with relapsing-remitting multiple sclerosis: a randomised, placebo-controlled, phase 2 trial.

    Rhonda R. Voskuhl;He Jing Wang;T. C.Jackson Wu;Nancy L. Sicotte

  • Varicella-zoster virus infections in patients treated with fingolimod: Risk assessment and consensus recommendations for management

    Ann M. Arvin;Jerry S. Wolinsky;Ludwig Kappos;Michele I. Morris

  • Glucocorticoid receptors in depression: relationship to the dexamethasone suppression test.

    G J Gormley;M T Lowy;A T Reder;V D Hospelhorn

  • Immunomodulatory activity of interferon-beta

    Lloyd H. Kasper;Anthony T. Reder

  • COMBINING BETA INTERFERON AND ATORVASTATIN MAY INCREASE DISEASE ACTIVITY IN MULTIPLE SCLEROSIS

    G. Birnbaum;B. Cree;I. Altafullah;M. Zinser

  • The Direct Effects of Fingolimod in the Central Nervous System: Implications for Relapsing Multiple Sclerosis

    Samuel F. Hunter;James D. Bowen;Anthony T. Reder

  • The mast cells of the multiple sclerosis brain

    Mohamed Z.M. Ibrahim;Mohamed Z.M. Ibrahim;Mohamed Z.M. Ibrahim;Anthony T. Reder;Rola Lawand;Wafaa Takash

  • Glucocorticoid resistance in depression: the dexamethasone suppression test and lymphocyte sensitivity to dexamethasone.

    Lowy Mt;Reder At;Antel Jp;Meltzer Hy

  • Activated suppressor cell dysfunction in progressive multiple sclerosis.

    J P Antel;M B Bania;A Reder;N Cashman

  • Interferon effects on interleukin-10 secretion Mononuclear cell response to interleukin-10 is normal in multiple sclerosis patients ☆

    A.M. Porrini;D. Gambi;A.T. Reder

  • Low expression of interferon-stimulated genes in active multiple sclerosis is linked to subnormal phosphorylation of STAT1

    Xuan Feng;Anthony L Petraglia;Michael Chen;Paul V Byskosh

  • Therapeutic role of beta-interferons in multiple sclerosis.

    Adil Javed;Anthony T. Reder

  • Sympathetic skin responses are decreased and lymphocyte beta-adrenergic receptors are increased in progressive multiple sclerosis.

    Joseph W. Karaszewski;Anthony T. Reder;Ricardo A Maselli;Margaret Brown

  • Methylation patterns of cell-free plasma DNA in relapsing-remitting multiple sclerosis.

    Thomas Liggett;Anatoliy Melnikov;Shilpa Tilwalli;Qilong Yi

  • Longitudinal analyses of the effects of neutralizing antibodies on interferon beta-1b in relapsing-remitting multiple sclerosis.

    A John Petkau;Richard A White;George C Ebers;Anthony T Reder

  • COVID-19 in Patients with Multiple Sclerosis: Associations with Disease-Modifying Therapies.

    Anthony T Reder;Diego Centonze;Maria L Naylor;Anjali Nagpal

Frequent Co-Authors

Jack P. Antel
Jack P. Antel McGill University
Barry G. W. Arnason
Barry G. W. Arnason University of Chicago
Douglas S. Goodin
Douglas S. Goodin University of California, San Francisco
George C. Ebers
George C. Ebers University of Oxford
Dawn Langdon
Dawn Langdon Royal Holloway University of London
Gary Cutter
Gary Cutter University of Alabama at Birmingham
Fred D. Lublin
Fred D. Lublin Icahn School of Medicine at Mount Sinai
Mark S. Freedman
Mark S. Freedman Ottawa Hospital
Bianca Weinstock-Guttman
Bianca Weinstock-Guttman University at Buffalo, State University of New York
Herbert Y. Meltzer
Herbert Y. Meltzer Northwestern University

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Studying Immunology in the USA opens doors to diverse healthcare and scientific careers. For those interested in advancing clinical skills quickly, an accelerated nurse practitioner program offers a fast track to becoming advanced practice nurses, blending immunology knowledge with patient care expertise.

If you are new to the medical field, pursuing one of the best online BSN programs for non nurses might be ideal. These programs are designed to transition non-nursing graduates into nursing professionals, providing a strong foundation in biological sciences related to immunology.

For those seeking quicker entry into nursing, exploring accelerated nursing programs near me can provide accessible pathways with less competitive admission criteria, allowing you to integrate immunology studies into your nursing education sooner.

Similarly, easy admission LPN programs offer a practical route for becoming licensed practical nurses. These programs require minimal admission hurdles and build a solid clinical skillset, complementing immunology knowledge applicable in many healthcare settings.

Best Scientists Citing Anthony T. Reder

Trending Scientists

Recently Published Articles